Literature DB >> 24852117

BINGO: targeted therapy for advanced biliary-tract cancer.

Juan W Valle1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24852117     DOI： 10.1016/S1470-2045(14)70238-4

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  3 in total

1.  Oncogenic potential of IDH1R132C mutant in cholangiocarcinoma development in mice.

Authors:  Ning Ding; Li Che; Xiao-Lei Li; Yan Liu; Li-Jie Jiang; Biao Fan; Jun-Yan Tao; Xin Chen; Jia-Fu Ji
Journal:  World J Gastroenterol       Date:  2016-02-14       Impact factor: 5.742

2.  IMbrave 151: a randomized phase II trial of atezolizumab combined with bevacizumab and chemotherapy in patients with advanced biliary tract cancer.

Authors:  Stephen P Hack; Wendy Verret; Sohail Mulla; Bo Liu; Yulei Wang; Teresa Macarulla; Zhenggang Ren; Anthony B El-Khoueiry; Andrew X Zhu
Journal:  Ther Adv Med Oncol       Date:  2021-07-31       Impact factor: 8.168

3.  Stathmin 1 expression predicts prognosis and benefits from adjuvant chemotherapy in patients with gallbladder carcinoma.

Authors:  Xiaobo Bo; Jie Wang; Qiang Fu; Yueqi Wang; Houbao Liu; Jiejie Xu
Journal:  Oncotarget       Date:  2017-07-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.